Bloodless glucose monitor to enter trials this year
This article was originally published in Clinica
Executive Summary
Clinical trials are due to begin later this year of a novel glucose monitoring product that its developer, MicroSense International, claims will combine the best features available in conventional finger-stick based methods with a cost-competitive, painless and blood-free system. MicroSense, a St Louis, Missouri-based privately held development stage company, believes that by eliminating the discomfort associated with blood glucose monitoring, patients will gain greater control over their insulin management and an associated decline in complications.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.